Dr. Donna J. Hanes, MD

Dr. Hanes practices at Chestnut Square Dialysis Center in Baltimore, Maryland.

Dr. Hanes' NPI, 1114970100, was assigned on May 18, 2006. Dr. Hanes graduated from University of Maryland School of Medicine - Baltimore in 1992. Dr. Hanes holds Maryland license D47161.

Dr. Hanes' primary practice is Chestnut Square Dialysis Center, at 3303 Chestnut Avenue, Baltimore, MD 21211 in Baltimore City. The practice phone is (301) 366-5400.

Dr. Hanes' primary practice is Chestnut Square Dialysis Center in Baltimore, Maryland. Dr. Hanes is also affiliated with University of Maryland Medical Center. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology. Dmand AI also links Dr. Hanes to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hanes practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hanes' primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Hanes is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Hanes' licenses on file in 2 states: Maryland and Florida.

Dmand AI lists acute kidney failure, chronic kidney disease and kidney disease among the conditions Dr. Hanes treats.

CMS data shows 526 Medicare services from Dr. Hanes across 6 procedure codes in 2024, for 166 Medicare patients. Medicare paid $106,304 for them.

CMS counts 166 Medicare patients who saw Dr. Hanes in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 4.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hanes' median patient age at 65, with 52% women.

In 2024, Dr. Hanes wrote 1,315 Medicare Part D claims for 141 patients. 91% of them were for generic drugs. CMS names the drug for 1,010 of them, across 32 drugs with 11 or more claims each, at $109,234 in total drug cost. In 2023, CMS named 1,165 claims across 35 drugs.

Dr. Hanes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hanes as offering telehealth.

Dmand AI links 4 papers to Dr. Hanes, published from 2018 to 2022. The most frequent topics are Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists and Kidney Transplantation. Dr. Hanes' most frequent co-authors are Luis Fernando Gimenez, MD, Bernard Georges Jaar, MD and Sarah A. Schmalzle, MD.

CMS Open Payments shows 80 general payments to Dr. Hanes from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 38% of the total. Horizon Pharma plc paid the most, $2,378.

Dmand AI lists 1 award for Dr. Hanes, most recently CMS Stage 1 EHR in 2013.

Dr. Hanes graduated from University of Maryland School of Medicine - Baltimore in 1992.

Dr. Hanes is in network with 11 carriers, including Aetna, CareFirst BlueCross BlueShield and Cigna. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.